{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:16:56Z","timestamp":1783397816030,"version":"3.54.6"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101173","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:22:28Z","timestamp":1776295348000},"page":"101173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Single fraction based-partial breast irradiation: 10-year results of the SiFEBI phase 2 prospective trial"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3813-7983","authenticated-orcid":false,"given":"Laura","family":"Haas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Schiappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-3245","authenticated-orcid":false,"given":"Jean-Michel","family":"Hannoun-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101173_b0005","unstructured":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries - Bray - 2024 - CA: A Cancer Journal for Clinicians - Wiley Online Library."},{"key":"10.1016\/j.ctro.2026.101173_b0010","unstructured":"Cancer Tomorrow. International Agency for Research Cancer. World Health Organization. Estimated number of new cases from 2022 to 2050, Females, age [70-85+] Breast. https:\/\/gco.iarc.fr\/tomorrow\/en\/dataviz\/trends?multiple_populations=1&types=0&cancers=20&age_start=14&sexes=2."},{"key":"10.1016\/j.ctro.2026.101173_b0015","unstructured":"BCRF. Breast Cancer in the Elderly | BCRF. Breast Cancer Research Foundation. 2025."},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5152\/ejbh.2019.4997","article-title":"Prevalence of molecular subtypes of breast cancer: a single institutional experience of 2062 patients","volume":"16","author":"Pandit","year":"2019","journal-title":"Eur J Breast Health"},{"issue":"3","key":"10.1016\/j.ctro.2026.101173_b0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2026.101173_b0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ctro.2026.101173_b0035","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJMoa040595","article-title":"Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer","volume":"351","author":"Fyles","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ctro.2026.101173_b0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2006.12.045","article-title":"Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer","volume":"68","author":"P\u00f6tter","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10237","key":"10.1016\/j.ctro.2026.101173_b0045","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"10015","key":"10.1016\/j.ctro.2026.101173_b0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ctro.2026.101173_b0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.brachy.2017.11.008","article-title":"Accelerated partial breast irradiation for suitable elderly women using a single fraction of multicatheter interstitial high-dose-rate brachytherapy: early results of the single-fraction elderly breast irradiation (SiFEBI) phase I\/II trial","volume":"17","author":"Hannoun-L\u00e9vi","year":"2018","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brachy.2019.10.007","article-title":"Accelerated partial breast irradiation in the elderly: 5-Year results of the single fraction elderly breast irradiation (SiFEBI) phase I\/II trial","volume":"19","author":"Hannoun-L\u00e9vi","year":"2020","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.ctro.2026.101173_b0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.radonc.2010.01.014","volume":"94","author":"Polg\u00e1r","year":"2010","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/02841867809127689","article-title":"The paris system in interstitial radiation therapy","volume":"17","author":"Pierquin","year":"1978","journal-title":"Acta Radiol Oncol Radiat Phys Biol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101173_b0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101173_b0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0360-3016(79)90729-6","article-title":"Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast","volume":"5","author":"Harris","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2026.101173_b0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/A:1026166518203","article-title":"Breast cancer in elderly women: is partial breast irradiation a good alternative","volume":"81","author":"Hannoun-Levi","year":"2003","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.ctro.2026.101173_b0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.brachy.2012.06.004","article-title":"GERICO-03 phase II trial of accelerated and partial breast irradiation in elderly women: feasibility, reproducibility, and impact on functional status","volume":"12","author":"Hannoun-Levi","year":"2013","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.ctro.2026.101173_b0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1470-2045(23)00018-9","article-title":"Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial","volume":"24","author":"Strnad","year":"2023","journal-title":"Lancet Oncol"},{"issue":"10099","key":"10.1016\/j.ctro.2026.101173_b0100","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"issue":"10215","key":"10.1016\/j.ctro.2026.101173_b0105","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ctro.2026.101173_b0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.prro.2023.03.006","article-title":"Three-fraction accelerated partial breast irradiation (apbi) delivered with interstitial brachytherapy is safe: first results from the tri-fraction radiation therapy used to minimize patient hospital trips (TRIUMPH-T) trial","volume":"13","author":"Yashar","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101173_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110543","article-title":"Five-year results of the very accelerated partial breast irradiation VAPBI phase I-II GEC-ESTRO trial","volume":"201","author":"Guinot","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101173_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110217","article-title":"Very accelerated partial breast irradiation in 1 or 2 days: late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort","volume":"194","author":"Hannoun-Levi","year":"2024","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijrobp.2021.03.052","article-title":"APBI versus ultra-APBI in the elderly with low-risk breast cancer: a comparative analysis of oncological outcome and late toxicity","volume":"111","author":"Hannoun-L\u00e9vi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2026.101173_b0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.brachy.2017.06.006","article-title":"Accelerated partial breast irradiation for elderly women with early breast cancer: a compromise between whole breast irradiation and omission of radiotherapy","volume":"16","author":"Sumodhee","year":"2017","journal-title":"Brachytherapy"},{"issue":"10215","key":"10.1016\/j.ctro.2026.101173_b0135","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ctro.2026.101173_b0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijrobp.2006.12.007","article-title":"Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation","volume":"68","author":"Vicini","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2026.101173_b0145","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1245\/s10434-013-3233-x","article-title":"Breast-conservative surgery with and without radiotherapy in patients aged 55\u201375 years with early-stage breast cancer: a prospective, randomized, multicenter trial analysis after 108 months of median follow-up","volume":"21","author":"Tinterri","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101173_b0150","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.23.02270","article-title":"Omission of radiotherapy after breast-conserving surgery for women with breast cancer with low clinical and genomic risk: 5-year outcomes of IDEA","volume":"42","author":"Jagsi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2026.101173_b0155","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMoa2302344","article-title":"Omitting Radiotherapy after Breast-Conserving Surgery in Luminal a Breast Cancer","volume":"389","author":"Whelan","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ctro.2026.101173_b0160","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.11909","article-title":"Dynamic projection of medication nonpersistence and nonadherence among patients with early breast cancer","volume":"7","author":"Rinder","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1470-2045(24)00661-2","article-title":"Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial","volume":"26","author":"Meattini","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101173_b0170","first-page":"1","article-title":"Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged \u2265 60 years with Early-stage breast cancer (EPOPE): the rationale for a GEC-ESTRO randomized phase III-controlled trial","volume":"29","author":"Hannoun-Levi","year":"2021","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13014-019-1448-0","article-title":"Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly","volume":"14","author":"Kinj","year":"2019","journal-title":"Radiat Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2026.101173_b0180","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/bjs.6208","article-title":"Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancer","volume":"95","author":"Sacchini","year":"2008","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.ctro.2026.101173_b0185","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1245\/s10434-012-2671-1","article-title":"Dosimetric feasibility and acute toxicity in a prospective trial of ultrashort-course accelerated partial breast irradiation (APBI) using a multi-lumen balloon brachytherapy device","volume":"20","author":"Khan","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2026.101173_b0190","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/COC.0000000000000402","article-title":"Six-year results from a phase I\/II trial for hypofractionated accelerated partial breast irradiation using a 2-day dose schedule","volume":"41","author":"Wilkinson","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2016.04.035","article-title":"A novel form of breast intraoperative radiation therapy with CT-guided high-dose-rate brachytherapy: results of a prospective phase 1 clinical trial","volume":"96","author":"Showalter","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2018.12.025","article-title":"Three-fraction intracavitary accelerated partial breast brachytherapy: early provider and patient-reported outcomes of a novel regimen","volume":"104","author":"Jethwa","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101173_b0205","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0959-8049(22)01483-6","article-title":"Accelerated partial breast irradiation (APBI) in a single 18 Gy fraction with high-dose-rate brachytherapy (HDR)","volume":"175","author":"Anchuelo","year":"2022","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/XCS.0000000000000869","article-title":"Novel form of breast intraoperative radiation therapy with CT-guided high-dose-rate brachytherapy: interim results of a prospective phase-II clinical trial","volume":"238","author":"Turkheimer","year":"2024","journal-title":"J Am Coll Surg"},{"issue":"2","key":"10.1016\/j.ctro.2026.101173_b0215","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijrobp.2024.09.019","article-title":"Dose deintensified 3-day photon, proton, or brachytherapy: a nonrandomized controlled partial breast irradiation trial","volume":"121","author":"Mutter","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ctro.2026.101173_b0220","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ijrobp.2025.02.012","article-title":"Preoperative single fraction stereotactic partial breast irradiation for early-stage breast cancer patients with gammapod technology: pathologic findings and Ki-67 evaluation","volume":"122","author":"Reverberi","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"25","key":"10.1016\/j.ctro.2026.101173_b0225","first-page":"06004","article-title":"Long-term results of a phase 2 prospective clinical trial of single-fraction, high-gradient adjuvant partial breast irradiation in early-stage, hormone-positive breast cancer","volume":"S0360\u20133016","author":"Lakomy","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0230","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1186\/s12885-025-15289-0","article-title":"Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-E","volume":"25","author":"Sperk","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2026.101173_b0235","unstructured":"Smanyk\u00f3 V. Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI) in Low-Risk Invasive or Ductal In Situ Breast Carcinoma - Phase II Multicenter Trial. 2025;."},{"key":"10.1016\/j.ctro.2026.101173_b0240","unstructured":"Fodor A. Accelerated Partial Breast Irradiation in One Fraction for Patients With Early-stage Disease and Favorable Histological Subtypes (Breast-1F). 2025;."},{"key":"10.1016\/j.ctro.2026.101173_b0245","unstructured":"Nichols E. GCC 1926- Phase Ib Dose Escalation of Single-Fraction Preoperative Stereotactic Partial-Breast Irradiation for Early-Stage Breast Cancer. 2024;."},{"key":"10.1016\/j.ctro.2026.101173_b0250","article-title":"Single-dose Preoperative Partial Breast Irradiation in Low-risk","author":"Van Den Bongard","year":"2024","journal-title":"Breast Cancer Patients"},{"key":"10.1016\/j.ctro.2026.101173_b0255","unstructured":"Kim Y. Impact of Preoperative Stereotactic Partial Breast Irradiation on Treatment Response, Treatment-related Toxicity, and Cosmetic Outcomes in Early-stage Breast Cancer: A Prospective, Phase II Clinical Trial. 2024."},{"issue":"1","key":"10.1016\/j.ctro.2026.101173_b0260","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40814-024-01557-6","article-title":"Magnetic resonance imaging-guided single-fraction preoperative radiotherapy for early-stage breast cancer (the RICE trial): feasibility study","volume":"10","author":"Qadir","year":"2024","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.ctro.2026.101173_b0265","doi-asserted-by":"crossref","unstructured":"Olson R. Phase II Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy: SHIFT-PB. 2025.","DOI":"10.1186\/s12885-025-14720-w"},{"key":"10.1016\/j.ctro.2026.101173_b0270","unstructured":"Zoberi I. Evaluation of Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma - BreaStBRT. 2025;."},{"key":"10.1016\/j.ctro.2026.101173_b0275","unstructured":"Zoberi I. Evaluation of Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma. 2025;."},{"key":"10.1016\/j.ctro.2026.101173_b0280","article-title":"Dose escalation trial of single fraction adjuvant stereotactic body partial breast irradiation (SB-PBI) for early stage","author":"Rahimi","year":"2025","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ctro.2026.101173_b0285","unstructured":"Hannoun-L\u00e9vi J-M. vAPBI 2: Very accelerated partial breast irradiation in 1 or 2 days: oncological results from the GEC-ESTRO VAPBI cohort."},{"key":"10.1016\/j.ctro.2026.101173_b0290","article-title":"A phase I dose escalation study of single fraction pre-operative partial breast (S-PBI) for early stage","author":"Rahimi","year":"2025","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ctro.2026.101173_b0295","unstructured":"Gerber N. Prone Partial Breast Irradiation (PBI): A Prospective Randomized Trial Comparing Five Versus Three Fractions. 2025."}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:43:55Z","timestamp":1783395835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"alternative-id":["S2405630826000686"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101173","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single fraction based-partial breast irradiation: 10-year results of the SiFEBI phase 2 prospective trial","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101173"}}